Stock Price
217.42
Daily Change
-0.61 -0.28%
Monthly
15.10%
Yearly
12.63%
Q4 Forecast
213.12

EPS Reference Time Actual Consensus Previous
2026-11-05 FY2026Q4 AM 4.15 4.10 3.96
2026-08-06 FY2026Q3 AM 3.23 3.13 3.68
2026-05-07 FY2026Q2 AM 2.90 2.78 3.35
2026-02-09 FY2026Q1 AM 2.91 2.81 3.43
2025-11-06 FY2025Q4 AM 3.96 3.92 3.81



Peers Price Chg Day Year Date
Terumo 2,461.00 61.00 2.54% 2.44% Nov/16
Agilent 172.91 -1.05 -0.60% 19.64% Nov/16
Abbott 108.62 0.10 0.09% -16.82% Nov/16
Align Technology 167.50 -0.82 -0.49% 22.15% Nov/16
AngioDynamics 11.87 -0.12 -0.96% -1.98% Nov/13
Baxter International 25.77 -0.04 -0.15% 39.52% Nov/16
Becton, Dickinson and Co. 217.42 -0.61 -0.28% 12.63% Nov/16
Bio-Rad Laboratories 366.36 -4.12 -1.11% 16.99% Nov/13
Boston Scientific 44.13 -0.21 -0.47% -57.03% Nov/16
Cooper Companies 62.75 0.10 0.16% -13.00% Nov/16

Indexes Price Day Year Date
US Index 500 7479 -82.70 -1.09% 12.09% Nov/16

Becton, Dickinson and Co. traded at $217.42 this Monday November 16th, decreasing $0.61 or 0.28 percent since the previous trading session. Looking back, over the last four weeks, Becton, Dickinson and Co. lost 15.10 percent. Over the last 12 months, its price rose by 12.63 percent. Looking ahead, we forecast Becton, Dickinson and Co. to be priced at 213.12 by the end of this quarter and at 199.06 in one year, according to Trading Economics global macro models projections and analysts expectations.

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.